These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1982327)

  • 21. Congestive heart failure in patients with normal left ventricular systolic function: a manifestation of diastolic dysfunction.
    Gaasch WH
    Herz; 1991 Feb; 16(1):22-32. PubMed ID: 1673955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy.
    Louie EK; Edwards LC
    Prog Cardiovasc Dis; 1994; 36(4):275-308. PubMed ID: 7904358
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative effects of calcium-channel blockers and beta-adrenergic blocker on early diastolic time intervals and A-wave ratio in patients with hypertrophic cardiomyopathy.
    Doiuchi J; Hamada M; Ito T; Kokubu T
    Clin Cardiol; 1987 Jan; 10(1):26-30. PubMed ID: 2880684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M; Hopf R; Keller M
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy--therapy with slow channel inhibiting agents.
    Chatterjee K; Raff G; Anderson D; Parmley WW
    Prog Cardiovasc Dis; 1982; 25(3):193-210. PubMed ID: 6216500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy.
    Pollick C
    Am J Cardiol; 1995 Mar; 75(8):652. PubMed ID: 7734026
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.
    Pacileo G; De Cristofaro M; Russo MG; Sarubbi B; Pisacane C; Calabrò R
    Can J Cardiol; 2000 Feb; 16(2):146-52. PubMed ID: 10694584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 29. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
    Park MH; Gilligan DM; Bernardo NL; Topaz O
    Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual case of apical hypertrophic cardiomyopathy in a transplanted heart.
    D'Andrea A; Scarafile R; Ferrara I; De Rimini ML; Muto P; Russo MG; Calabrò R
    Monaldi Arch Chest Dis; 2010 Dec; 74(4):192-4. PubMed ID: 21329272
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of diastolic filling in preserving left ventricular stroke volume--an MRI study.
    Offen S; Celermajer D; Semsarian C; Puranik R
    Int J Cardiol; 2013 Sep; 168(2):1596-8. PubMed ID: 23419962
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Maintenance therapy and various tests during follow-up of cardiomyopathies].
    Ogasawara S; Kimata S
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):231-4. PubMed ID: 8098350
    [No Abstract]   [Full Text] [Related]  

  • 34. Verapamil in the treatment of hypertrophic cardiomyopathy.
    Rosing DR; Epstein SE
    Ann Intern Med; 1982 May; 96(5):670-2. PubMed ID: 6122414
    [No Abstract]   [Full Text] [Related]  

  • 35. [Left ventricular dysfunctions after correction of aortic stenosis].
    Krichevskiĭ LA; Kozlov IA
    Anesteziol Reanimatol; 2008; (5):30-2. PubMed ID: 19105254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Pharmacotherapy for Hypertrophic Cardiomyopathy.
    Wong TC; Martinez M
    Cardiol Clin; 2019 Feb; 37(1):113-117. PubMed ID: 30447712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of hypertrophic obstructive cardiomyopathy with marked T wave changes during the short-term].
    Kageyama F; Iida H; Yositomi A; Ikegaya H; Okano H; Fujimoto K; Tagata M; Nagao M; Yosimi T; Itou T
    Kokyu To Junkan; 1993 Jan; 41(1):69-73. PubMed ID: 8094573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pitfalls in the differentiation between athlete's heart and hypertrophic cardiomyopathy.
    Scharhag J; Kindermann W
    Clin Res Cardiol; 2009 Jul; 98(7):465-6; author reply 467-8. PubMed ID: 19517053
    [No Abstract]   [Full Text] [Related]  

  • 39. Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Saito M; Okayama H; Yoshii T; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Shigematsu Y; Funada J; Hamada M; Higaki J
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):207-12. PubMed ID: 21052009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.
    Andries G; Yandrapalli S; Naidu SS; Panza JA
    Cardiol Rev; 2018; 26(5):239-244. PubMed ID: 29746257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.